Teleconsultation in Counter-reference Between Tertiary and Primary Care for Patients With Benign Prostatic Hyperplasia

Hospital de Clinicas de Porto Alegre299 enrolled

Overview

To evaluate the effectiveness of the use of teleconsultation in qualifying counter-reference between tertiary and primary care for patients with stable benign prostatic hyperplasia (BPH) symptoms.

The effectiveness of the use of teleconsultation will be evaluated by the initial international prostate symptom score (IPSS) in patients randomized to the standard monitoring (tertiary hospital) and teleconsultation monitoring (primary care) and after twelve months.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

299

Conditions

Prostatic Hyperplasia

Interventions

TeleconsultationOTHER

Teleconsultation - the teleconsultation usage in chronic diseases, such as benign hyperplasia, seems to be a promising scenario. Once the patient symptoms are evaluated and diagnosed as a stable disease he is able to keep his treatment annually. In a way to do not overload de tertiary system, such monitoring could be done under a teleconsultation with a urological supervision in the primary care.

Hospital (control)OTHER

The patient will keep his usual care at the tertiary care.

Eligibility

Sex: MALEMin age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * males, over forty years, with clinical diagnosis or imaging diagnosis of benign prostate hyperplasia (ultrasonography, computed tomography, magnetic resonance imaging) with stable low urinary tract symptoms and International Prostate Symptom Score lower or equal to 25 points followed at tertiary care clinic. Exclusion Criteria: * low urinary tract symptoms and International Prostate Symptom Score over to 25 points, inadequate clinical treatment response, surgical treatment indication, suspicion of prostate malignancy or urethra stricture or neurogenic bladder and illiterates.

Locations (1)

Hospital De Clinicas De Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Outcomes

Primary Outcomes

Change from baseline Low Urinary Tract Symptoms (LUTS)

Low urinary tract symptoms are assessed through International Prostate Score System (IPSS) which includes seven main important symptoms of benign prostate hyperplasia, validated to portuguese. Each symptom is graduated from zero to five. This score classifies the symptoms of the lower urinary tract that will be assessed at randomization and after twelve months in each arm of the study.

Time frame: 12 months

Secondary Outcomes

Occurrence of Acute Urinary Retention (AUR)

The occurrence of spontaneous obstruction of the urinary flow secondary to the benign prostatic hyperplasia.

Time frame: 12 months

Change from baseline Serum Creatinine

Serum creatinine values will be assessed at randomization and after twelve months

Time frame: 12 months

Change from baseline Serum Urea

Serum urea values will be assessed at randomization and after twelve months

Time frame: 12 months

Change from baseline Prostatic Specific Antigen (PSA)

Prostatic specific antigen serum values will be assessed at randomization and after twelve months.

Time frame: 12 months

Occurrence of Urinary infection

Occurrence of urinary tract infection during the study will be assessed through urine cultures

Time frame: 12 months

Adhesion to Medications

The adhesion to prescribed medications will be assessed after 12 months of the randomization

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.